Interim C-reactive protein levels predict the prognosis of patients with metastatic colorectal cancer receiving immunotherapy: a retrospective cohort study
Background: Serum C-reactive protein (CRP) level is frequently considered a prognostic predictor of immunotherapy. However, the prognostic role of the interim serum CRP levels before the third course of immunotherapy (CRP-C3) in patients with metastatic colorectal cancer (mCRC) receiving immunothera...
Saved in:
Main Authors: | Hai-Yan Fu, Yi-Yang Zhang, Jin-Shan Huang, Jin-Xin Hu, Kun-Hao Bai, Zhi-Qiang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-07-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359251356581 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting prognosis and immunotherapy response of ferroptosis-related genes in colorectal cancer
by: Hongyun Wei, et al.
Published: (2025-06-01) -
Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer
by: Karen-Lise Garm Spindler, et al.
Published: (2018-11-01) -
Immunotherapy in metastatic prostate cancer
by: Liam Dwyer, et al.
Published: (2025-06-01) -
Role of telomere maintenance genes as a predictive biomarker for colorectal cancer immunotherapy response and prognosis
by: Zhikai Wang, et al.
Published: (2025-07-01) -
Interim report.
Published: (1980)